The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

Endpoint management has become more challenging for IT teams as organisations adopt remote work, cloud services, and a wider ...

The Expanse's story is far from over, with unadapted novels holding the key to its most ambitious ideas yet. Only a return ...

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...

The tech firm reveals a focus on AI agents, Copilot expansion, Microsoft 365 updates, and global infrastructure investment.

Endpoint-only views lack the cross-domain context and timeliness needed for prevention. Using multiple point solutions for different aspects of security only increases dashboard fatigue, making it ...

With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former ...

Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

Independent analysis highlights Automox’s leadership in advancing cloud-native endpoint operations with speed, clarity, and ...

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid ...